Implications of post-gadolinium MRI results in 13 cases with posterior reversible encephalopathy syndrome
- PMID: 15741018
- DOI: 10.1016/j.ejrad.2004.05.015
Implications of post-gadolinium MRI results in 13 cases with posterior reversible encephalopathy syndrome
Abstract
Background: There is a relative lack of definitive information about the contrast-enhancement characteristics of lesions in posterior reversible encephalopathy syndrome (PRES).
Objective: Evaluation of contrast-enhanced MRI findings in PRES with a special emphasis on pathophysiology of post-gadolinium behavior of these lesions.
Materials and methods: Contrast-enhanced 1.5 T MRI findings and relevant clinical data of the patients were retrospectively reviewed on 13 cases (six males, seven females; age range: 22-78; mean age 47). Although fluid attenuated inversion recovery (FLAIR) and diffusion-weighted MR images were considered for identification of the entity, primarily post-contrast T1-weighted MR images were searched for traces of enhancement in the lesions.
Results: No definitely enhancing lesion was identified in the MR images obtained in 6-48 h after onset of symptoms (mostly headaches, seizures and cortical visual field deficits) in this series. Severity of disease indicated by small hemorrhages, confluence of lesions or progression to cytotoxic edema did not seem to alter this result. Typical lesion characteristics were consistent with vasogenic edema on FLAIR and diffusion MR images. Acute elevation of blood pressure on chronic hypertensive background was responsible in four, eclampsia in three, uremia with blood pressure fluctuations in three, and cyclosporine-toxicity in three cases.
Conclusion: Although occasional enhancing brain lesions have been reported in the literature on PRES, contrast-enhancement of lesions may be a factor of scan timing and underlying etiology. Prospective studies with larger series on PRES are required for better evaluation of contrast-enhancement in MRI with respect to scan timing, which in turn may help understand its pathophysiology better.
Similar articles
-
Diagnostic value of contrast-enhanced fluid-attenuated inversion-recovery MRI for intracranial tumors in comparison with post-contrast T1W spin-echo MRI.Chin Med J (Engl). 2006 Mar 20;119(6):467-73. Chin Med J (Engl). 2006. PMID: 16584644
-
Relationship between contrast enhancement on fluid-attenuated inversion recovery MR sequences and signal intensity on T2-weighted MR images: visual evaluation of brain tumors.J Magn Reson Imaging. 2005 Jun;21(6):694-700. doi: 10.1002/jmri.20331. J Magn Reson Imaging. 2005. PMID: 15906343
-
[Cerebral lesions in acute arterial hypertension: the characteristic MRI in hypertensive encephalopathy].Rofo. 2006 Jun;178(6):618-26. doi: 10.1055/s-2006-926631. Epub 2006 May 15. Rofo. 2006. PMID: 16703498 German.
-
Neuroimaging in posterior reversible encephalopathy syndrome.J Neuroimaging. 2004 Apr;14(2):89-96. J Neuroimaging. 2004. PMID: 15095552 Review.
-
Magnetic resonance imaging in Posterior Reversible Encephalopathy Syndrome: report of three cases and review of literature.Arch Gynecol Obstet. 2005 Jan;271(1):79-85. doi: 10.1007/s00404-004-0622-1. Epub 2004 Oct 9. Arch Gynecol Obstet. 2005. PMID: 15480723 Review.
Cited by
-
Posterior Reversible Encephalopathy Syndrome: The Spectrum of MR Imaging Patterns.Clin Neuroradiol. 2015 Jun;25(2):161-71. doi: 10.1007/s00062-014-0293-7. Epub 2014 Feb 20. Clin Neuroradiol. 2015. PMID: 24554281
-
Medication neurotoxicity in children.Pediatr Radiol. 2011 Nov;41(11):1455-64. doi: 10.1007/s00247-011-2191-3. Epub 2011 Jul 23. Pediatr Radiol. 2011. PMID: 21785849
-
Utility and Significance of Gadolinium-Based Contrast Enhancement in Posterior Reversible Encephalopathy Syndrome.AJNR Am J Neuroradiol. 2016 Mar;37(3):415-22. doi: 10.3174/ajnr.A4563. Epub 2015 Nov 12. AJNR Am J Neuroradiol. 2016. PMID: 26564441 Free PMC article.
-
Frequency of ischaemic stroke and intracranial haemorrhage in patients with reversible cerebral vasoconstriction syndrome (RCVS) and posterior reversible encephalopathy syndrome (PRES) - A systematic review.Eur J Neurol. 2024 May;31(5):e16246. doi: 10.1111/ene.16246. Epub 2024 Mar 12. Eur J Neurol. 2024. PMID: 38470001 Free PMC article.
-
Delayed Posterior Reversible Leukoencephalopathy Syndrome Triggered by FLOT Chemotherapy.Front Neurol. 2020 Jan 30;10:1405. doi: 10.3389/fneur.2019.01405. eCollection 2019. Front Neurol. 2020. PMID: 32082236 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical